Skip to content

Investor Relations / Publications / Publications Search

Publications Search

Sherratt SCR, Juliano RA, Mason RP. Eicosapentaenoic acid (EPA) has optimal chain length and degree of unsaturation to inhibit oxidation of small dense LDL and membrane cholesterol domains as compared to related fatty acids in vitro. Biochimica Biophysica Acta Biomembrane. 2020; epub ahead of print.

https://www.sciencedirect.com/science/article/pii/S0005273620300791
Sherratt S, Bhatt D, Mason P. Eicosapentaenoic acid inhibits membrane cholesterol domains compared to other omega-3 fatty acids under conditions of hyperglycemia [abstract 005]. Can J Cardiol. 2020;36(10 suppl):S2-S3. https://www.onlinecjc.ca/article/S0828-282X(20)30644-9/fulltext
Eicosapentaenoic acid (EPA) containing phospholipids modulate membrane structure.
Sherratt SCR, Mason RP. Eicosapentaenoic acid (EPA) containing phospholipids modulate membrane structure. Presented at the European Atherosclerosis Society meeting, October 4-7, 2020 (virtual).

Amarin Corporation